Final Programme

Scientific Programme Sunday, April 2, 2006
Erato Rapid methods for the identification of
15:30– bacterial clones and pathogens
17:30
Chairpersons: Paula Kriz (Prague, CZ)
Fred C. Tenover (Atlanta, US)
O166 Mixed whole genome microarray technology
15:30 discerns a hospital-adapted subtype of Enterococcus
faecium, comparable to multilocus
sequence typing clonal complex (CC) 17
H.L. Leavis, W.J.B. van Wamel, R.J.L. Willems,
F.H. Schuren, A.C. Fluit, M.J.M. Bonten
(Utrecht, Zeist, NL)
O167 Genetic relationship between Streptococcus
15:42 pneumoniae isolates responsible for a case of
meningitis and for asymptomatic carriage in
children attending a day-care centre in Lisbon
T. Figueiredo, M. Ramirez, I. Santos-Sanches,
S. Nunes, A. Brito-Avô, R.M. Barros, I. Peres,
H. de Lencastre (Lisbon, Oeiras, PT; New York, US)
O168 Changes in the distribution of hypervirulent
15:54 complexes of Neisseria meningitidis in the
Czech Republic
P. Kriz, J. Kalmusova, M. Musilek, J. Felsberg,
R. Haugvicova, D. Caugant, K. Jolley, M. Maiden
(Prague, CZ; Oslo, NO; Oxford, UK)
O169 Rapid diagnosis of bacterial vaginosis by
16:06 terminal restriction fragment length
polymorphism profiling
F. Thies, W. König, B. König (Magdeburg, DE)
O170 Development and validation of real-time
16:18 PCR assays for a multi-centre study to
assess the prevalence and epidemiology of
shiga-toxin producing Escherichia coli in the
Netherlands
T. Schuurman, A. Roovers, W.K. van der Zwaluw,
A.A. van Zwet, L.J.M. Sabbe, A.M.D. Kooistra-Smid,
Y.T.H.P. van Duynhoven (Groningen, Goes,
Bilthoven, Arnhem, NL)
O171 Based upon repeat patterns: variable
16:30 number of tandem repeat pattern analysis
to infer clonal groupings of Staphylococcus
aureus strains from spa typing data
T. Weniger, C. Berssenbruegge, A. Mellmann,
J. Rothgänger, M. Sammeth, J. Stoye,
D. Harmsen (Munster, Wurzburg, Bielefeld, DE)
O172 Multiple locus variable number tandem
16:42 repeat assays do not differentiate between
community-associated and healthcareassociated
lineages of methicillin-resistant
Staphylococcus aureus
F. Tenover, R. Vaughn, L. McDougal, G. Fosheim,
J. McGowan Jr. (Atlanta, US)
O173 Molecular typing of Mycobacterium
16:54 tuberculosis by mycobacterial interspersed
repetitive unit – variable-number tandem
repeat analysis in Lisbon in 2003
E. Fernandes, R. Macedo, C. Furtado, L. Brum,
I. Portugal (Lisbon, PT)
O174 Clinical impact of a rapid PCR-based
17:06 identification of staphylococci directly from
positive blood cultures
P. Agmon, I. Oren, R. Finkelstein, H. Sprecher
(Haifa, IL)
O175 Clinical evaluation of a molecular-based
17:18 assay for the detection of methicillin-resistant
Staphylococcus aureus and Staphylococcus
aureus in positive blood cultures
D. Fuller, T. Davis, M. Parker, R. Buckner, J. Talbott
(Indianapolis, US)
Integrated Symposia
Athena Readdressing the importance of
15:30– Gram-negative resistance: pathogens,
17:30 practice patterns, and pharmacotherapy
Chairpersons: Jacques F. Acar (Paris, FR)
Mark H. Wilcox (Leeds, UK)
15:30 Welcome and introduction
Jacques F. Acar (Paris, FR)
S176 Pathogens: a review of Gram-negative
15:40 resistance epidemiological data
Timothy R. Walsh (Bristol, UK)
S177 Practice patterns: current Gram-negative
16:10 treatment strategies
Mark H. Wilcox (Leeds, UK)
S178 Pharmacotherapy: new help in the fight
16:40 against Gram-negative resistance
Jean M. Carlet (Paris, FR)
17:10 Panel discussion – Questions and answers
Moderator: Jacques F. Acar (Paris, FR)
17:25 Concluding remarks
Jacques F. Acar (Paris, FR)
Integrated symposium arranged by
Wyeth Pharmaceuticals
www.escmid.org/eccmid2006 page 45